In contrast, in HeLa cells we found a stronger cytoplasmic localization after treatment supporting its role as an oncoprotein and confirming earlier studies from other groups showing cytoplasmic enrichment of p21 after Plk1 inhibition [40] and thus leading to a prevention of apoptosis induction in cancer cells [39, 41]. The gene discussed is PLK1; the disease is cancer.